Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Risks associated with vaccinations]

E Loupi1, S Baudard, H Debois

  • 1Département de Pharmacovigilance, Laboratoire Pasteur Mérieux Connaught, Lyon.

Annales De Medecine Interne
|December 16, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Causality assessment revisited in reply to Meyboom R.H.B.

Pharmacoepidemiology and drug safety·2004
Same author

[Which vaccination strategies for African meningococcal meningitis?].

Bulletin de la Societe de pathologie exotique (1990)·2003
Same author

A critical review of control strategies against meningococcal meningitis epidemics in sub-Saharan African countries.

Infection·2002
Same author

[Critical review of control strategies for meningococcal meningitis epidemics in Sub-Saharan Africa].

Bulletin de la Societe de pathologie exotique (1990)·2002
Same author

[Misuse and or overdose of BCG vaccine: evaluation over a 4-year period].

Therapie·2002
Same author

[Tolerance and efficiency of intravesical instillation of Calmette-Guérin in the prophylactic treatment of superficial bladder tumors, using a maintenance treatment].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2002
Same journal

[Consensus Development Conference on Thrombosis and Pregnancy. 14 March 2003, Paris, France. Proceedings].

Annales de medecine interne·2004
Same journal

Kartagener's syndrome and renal failure.

Annales de medecine interne·2004
Same journal

Inflammatory pseudotumor of lymph nodes.

Annales de medecine interne·2004
Same journal

[Necrolytic migratory erythema revealing glucagonoma without diabetes].

Annales de medecine interne·2004
Same journal

[Bilateral primary non-Hodgkin's lymphomas of the adrenals].

Annales de medecine interne·2004
Same journal

[Acute "pseudo-angiocholitis" due to colonic adenocarcinoma in a man with primary sclerosis cholangitis and ulcerative colitis].

Annales de medecine interne·2004
See all related articles

Vaccine adverse events are monitored to ensure safety, with rare events requiring specific studies to confirm causality. Proper vaccine use and information are crucial for minimizing risks.

Area of Science:

  • Immunology
  • Public Health
  • Pharmacovigilance

Background:

  • Vaccines, developed since Jenner and Pasteur, are vital for diminishing pathogen circulation and eradicating diseases through WHO immunization programs.
  • Monitoring adverse events post-vaccination is crucial for assessing vaccine risks, which vary by vaccine type.
  • Increasing attention is paid to adverse events as immunization rates rise and infectious disease incidence falls.

Purpose of the Study:

  • To highlight the importance of collecting and assessing adverse events following immunization.
  • To differentiate between expected and unexpected adverse events and their reporting mechanisms.
  • To emphasize the need for specific studies to establish causal relationships between vaccines and adverse events.

Main Methods:

Related Experiment Videos

  • Collection and assessment of adverse events reported after vaccine administration.
  • Utilizing spontaneous reporting and post-marketing surveillance studies (vaccino-vigilance).
  • Conducting specific studies to evaluate the causal relationship between vaccines and adverse events.

    • Main Results:

    • Adverse events associated with immunization vary by vaccine type.
    • Expected adverse events are frequently reported in clinical trials.
    • Rare, unexpected adverse events are identified through post-marketing surveillance.

    Conclusions:

    • Temporal association between vaccination and adverse events does not imply causation.
    • Post-marketing surveillance must be adapted for vaccines, considering the risks of the diseases they prevent.
    • Reducing immunization risks requires strict adherence to guidelines, contraindications, and providing adequate information to patients and healthcare providers.